BACKGROUND AND OBJECTIVES: Comorbid substance use disorders and mood and anxiety disorders are associated with more severe psychiatric symptoms, social and occupational impairment, and economic burden. To date, the majority of research has focused on comorbidity in illicit drug users, rather than prescription drug users. To address this gap in the literature, the present cross-sectional study investigated the clinical profiles of individuals with prescription opioid dependence with or without comorbid mood and anxiety disorders. METHODS: Ninety individuals with prescription opioid use were recruited to participate in the study procedures. All participants completed a structured clinical interview and series of self-report measures. RESULTS AND CONCLUSIONS: Of the 85 individuals with prescription opioid dependence, 47.1% (n = 40) were diagnosed with a comorbid mood or anxiety disorder. The findings showed that individuals with prescription opioid dependence and comorbid mood and anxiety disorders demonstrated significantly more severe alcohol use, psychiatric symptoms, and sleep impairment than individuals without comorbidity. SCIENTIFIC SIGNIFICANCE: The findings highlight the frequency and severity of co-occurring mood and anxiety disorders in individuals with prescription opioid dependence and suggest that integrated interventions are needed to address these growing problems.
BACKGROUND AND OBJECTIVES: Comorbid substance use disorders and mood and anxiety disorders are associated with more severe psychiatric symptoms, social and occupational impairment, and economic burden. To date, the majority of research has focused on comorbidity in illicit drug users, rather than prescription drug users. To address this gap in the literature, the present cross-sectional study investigated the clinical profiles of individuals with prescription opioid dependence with or without comorbid mood and anxiety disorders. METHODS: Ninety individuals with prescription opioid use were recruited to participate in the study procedures. All participants completed a structured clinical interview and series of self-report measures. RESULTS AND CONCLUSIONS: Of the 85 individuals with prescription opioid dependence, 47.1% (n = 40) were diagnosed with a comorbid mood or anxiety disorder. The findings showed that individuals with prescription opioid dependence and comorbid mood and anxiety disorders demonstrated significantly more severe alcohol use, psychiatric symptoms, and sleep impairment than individuals without comorbidity. SCIENTIFIC SIGNIFICANCE: The findings highlight the frequency and severity of co-occurring mood and anxiety disorders in individuals with prescription opioid dependence and suggest that integrated interventions are needed to address these growing problems.
Authors: Sudie E Back; Therese Killeen; Edna B Foa; Elizabeth J Santa Ana; Daniel F Gros; Kathleen T Brady Journal: Am J Psychiatry Date: 2012-07 Impact factor: 18.112
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Denise A Hien; Huiping Jiang; Aimee N C Campbell; Mei-Chen Hu; Gloria M Miele; Lisa R Cohen; Gregory S Brigham; Carrie Capstick; Agatha Kulaga; James Robinson; Lourdes Suarez-Morales; Edward V Nunes Journal: Am J Psychiatry Date: 2009-11-16 Impact factor: 18.112
Authors: Patricia Eckardt; Donald Bailey; Holli A DeVon; Cynthia Dougherty; Pamela Ginex; Cheryl A Krause-Parello; Rita H Pickler; Therese S Richmond; Eleanor Rivera; Carol F Roye; Nancy Redeker Journal: Nurs Outlook Date: 2020-04-09 Impact factor: 3.250
Authors: Adriaan W Bruijnzeel; Azin Behnood-Rod; Wendi Malphurs; Ranjithkumar Chellian; Robert M Caudle; Marcelo Febo; Barry Setlow; John K Neubert Journal: Behav Pharmacol Date: 2022-08-03 Impact factor: 2.277
Authors: Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman Journal: Am J Drug Alcohol Abuse Date: 2014-05-08 Impact factor: 3.829
Authors: Timothy M Doyle; Kali Janes; Zhoumou Chen; Peter M Grace; Emanuela Esposito; Salvatore Cuzzocrea; Tally M Largent-Milnes; William L Neumann; Linda R Watkins; Sarah Spiegel; Todd W Vanderah; Daniela Salvemini Journal: Pain Date: 2020-09-01 Impact factor: 7.926
Authors: Muhamad Y Elrashidi; Lindsey M Philpot; Priya Ramar; William B Leasure; Jon O Ebbert Journal: Health Serv Res Manag Epidemiol Date: 2018-04-19